Paroxysmal nocturnal haemoglobinuria: Long-term follow-up and prognostic factors

Lancet

Volumn 348, Issue 9027, 1996, Pages 573-577

  Socié, Gérard ^a   Mary, Jean Yves ^b   De Gramont, Aimery ^c   Rio, Bernard ^d   Leporrier, Michel ^e   Rose, Christian ^f   Heudier, Phillippe ^g   Rochant, Henry ^h   Cahn, Jean Yves ⁱ   Gluckman, Eliane ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b INSERM   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d HÔTEL DIEU   (France)

^e CAEN UNIVERSITY HOSPITAL   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g University of Côte d'Azur   (France)

^h HENRI MONDOR HOSPITAL   (France)

ⁱ UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ACUTE LEUKEMIA; ARTICLE; CAUSE OF DEATH; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; THROMBOSIS;

EID: 16044365965     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)12360-1     Document Type: Article

References (29)

1. 1 Rotoli B, Luzzatto L. Paroxysmal nocturnal hemoglobinuria. Semin Hematol 1989; 26: 201-07.
2. 2 Rosse WF. Paroxysmal nocturnal hemoglobinuria. In: Stossel TP, Lux SE, eds. Principles and practice of hematology. Philadelphia: Lippincott, 1995: 367-76.
3. 3 Yeh ETH, Rosse WF. Paroxysmal nocturnal hemoglobinuria and the glycosylphosphatidylinositol anchor. J Clin Invest 1994; 93: 2305-10.
4. 4 Takeda J, Miyata T, Kawagoe K, et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 1993; 73: 703-11.
5. 5 Bessler M, Mason P, Hillmen P, et al. Paroxysmal nocturnal hemoglobinuria is caused by somatic mutations in the PIG-A gene. EMBO J 1994; 13: 110-17.
6. 6 Pramoonjago P, Wanachiwanawin W, Chinprasertak S, Pattanapanayasat K, Takeda J, Kinoshita T. Somatic mutations of PIG-A in Thai patients with paroxysmal nocturnal hemoglobinuria. Blood 1995; 86: 1736-39.
7. 7 Saso R, Marsh J, Cevrevska L, Horrowitz MM, Gale RP, Gordon-Smith E. Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: a report from the International Bone Marrow Transplant Registry. Exp Hematol 1995; 23: 866 (abstr).
8. 8 Antin JH, Ginsgurg D, Smith BR, Nathan DG, Orkin SH, Rappeport JM. Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment. Blood 1985; 66: 1247-50.
9. 9 Kawahara K, Witherspoon RP, Storb R. Marrow transplanatation for paroxysmal nocturnal hemoglobinuria. Am J Hematol 1992; 39: 283-88.
10. 10 De Gramont A, Debray J. Hémoglobinurie paroxystique nocturne: synthèse et réflexions à partir d'une série francophone de 151 patients. Rev Med Interne 1985; 6: 477-83.
11. 11 Dacie JV, Lewis M. Paroxysmal nocturnal hemoglobinuria: clinical manifestation, haematology, and nature of the disease. Series Haematol 1972; 3: 3-23.
12. 12 Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized trials requiring prolonged observations of each patient. Blood J Cancer 1977; 35: 1-39.
13. 13 Byar DP. Identification of prognostic factors. In: Buyse ME, Staquet MJ, Sylvester RJ, eds. Cancer clinical trials methods and practice. Oxford: Oxford Medical Publications, 1988: 423-43.
14. 14 Altman DG, De Stavola BL. Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates. Stat Med 1994; 13: 301-41.
15. 15 Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall, 1984.
16. 16 Grosby WH. Paroxysmal nocturnal hemoglobinuria: relation of the clinical manifestations to the underlying pathogenic mechanisms. Blood 1953; 8: 769-812.
17. 17 Dacie JV. Paroxysmal nocturnal hemoglobinuria. In: Dacie JV, ed. The haemolytic anaemias. New York: Grune and Stratton, 1967: 1128-60.
18. 18 Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995; 333: 1253-58.
19. 19 Fujioka S, Takayoshi T. Prognostic features of paroxysmal nocturnal hemoglobinuria in Japan. Acta Haematol JPN 1989; 52: 1386-94.
20. 20 Späth-Schwalbe E, Schrezenmeier H, Heimpel H. Paroxysmale nätliche hämoglobinurie: Klinische erfahrungen bei 40 patienten in einem zentrum über 25 jahre. Dtsch Med Wochenschr 1995; 120: 1027-33.
21. 21 Forman K, Sokol RJ, Hewitt S, Stamps BK. Paroxysmal nocturnal hemoglobinuria: a clinicopathological study of 26 cases. Acta Haematol 1984; 71: 217-26.
22. 22 Ware RE, Hall SE, Rosse WF. Paroxysmal nocturnal hemoglobinuria with onset in childhood and adolescence. N Engl J Med 1991; 325: 91-96.
23. 23 Lewis SM, Dacie JV. The aplastic anaemia-paroxysmal nocturnal hemoglobinuria syndrome. Br J Haematol 1967; 13: 236-51.
24. 24 Griscelli-Bennaceur A, Gluckman E, Scrobohaci ML, et al. Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link. Blood 1995; 85: 1354-63.
25. 25 Van Kamp H, Van Imhoff GW, De Wolf JTM, Smit JW, Halie MR, Vellenga E. The effect of cyclosporine on haematological parameters in patients with paroxysmal nocturnal hemoglobinuria. Br J Haematol 1995; 89: 79-82.
26. 26 Hartmann RC, Kolhouse F. Viewpoints on the management of paroxysmal nocturnal hemoglobinuria. Ser Haematol 1972; 3: 42-60.
27. 27 Peytermann R, Rhodes RS, Hartmann RC. Thrombosis in paroxysmal nocturnal hemoglobinuria with particular reference to progressive, diffuse hepatic venous thrombosis. Series Haematol 1972; 3: 115-36.
28. 28 Tichelli A, Gratwohl A, Nissen C, Speck B. Late clonal complications in severe aplastic anemia. Leuk Lymphoma 1994; 12: 167-75.
29. 29 Socié G, Henry-Amar M, Bacigalupo A, et al. Malignant tumors occurring after treatment of aplastic anemia. N Engl J Med 1993; 329: 1152-75.